Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Country's Decision or any other Communication
(DEC)
last updated: 25 Jun 2026
No
Commercial Release of the Poulvac ST Vaccine - Technical Opinion No. 2741/2010.
EN
17 Nov 2010
No
- Decision on LMOs for intentional introduction into the environment (according to Article 10 or domestic regulatory framework)
- Decision on LMOs for direct use as food or feed, or for processing (Article 11, LMOs-FFP)
No
Yes
-
Organization:Fort Dodge Saúde Animal ()Private sector (business and industry)Rua Luis Fernando Rodriguez, 1701 Vila Boa VistaCampinas, São Paulo
13064798, BrazilPhone: +55 19 37456240,Fax: +55 19 37456189,Email: elianaaguiar@cdn.com.br,Website: http://www.zoetis.com.br/index.br,
Yes
Yes
Yes
- LMOs for processing
No
Approval of the import and/or use of the LMO(s) without conditions
Yes
No
No
-
BCH-LMO-SCBD-105185-1 Living Modified Organism Poulvac® ST vaccineFort Dodge Saúde Animal | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
-
BCH-RA-BR-299524-1 Risk Assessment generated by a regulatory process Risk assessment of the Poulvac ST Vaccine - Technical Opinion No. 2741/2010.Poulvac® ST vaccine | SALTM, Production of medical or pharmaceutical compounds (human or animal)
- Commercial release 2741-2010.pdf [ Portuguese ]
